- Home
- NKSH vs NBTX Comparison
NKSH vs NBTX Comparison
Compare NKSH & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKSH | NBTX |
|---|---|---|
| Founded | 1891 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.2M | 1.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NKSH | NBTX |
|---|---|---|
| Price | $32.95 | $22.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 12.5K | ★ 49.9K |
| Earning Date | 01-22-2026 | 09-30-2025 |
| Dividend Yield | ★ 4.49% | N/A |
| EPS Growth | ★ 41.35 | N/A |
| EPS | ★ 2.04 | N/A |
| Revenue | ★ $51,980,000.00 | $11,930,711.00 |
| Revenue This Year | $2.95 | N/A |
| Revenue Next Year | $9.97 | $136.64 |
| P/E Ratio | $16.45 | ★ N/A |
| Revenue Growth | ★ 19.63 | N/A |
| 52 Week Low | $23.75 | $2.82 |
| 52 Week High | $33.92 | $30.35 |
Technical Indicators
Market Signals| Indicator | NKSH | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 73.37 | 57.57 |
| Support Level | $29.79 | $20.83 |
| Resistance Level | $30.72 | $23.77 |
| Average True Range (ATR) | 0.92 | 0.88 |
| MACD | 0.40 | 0.17 |
| Stochastic Oscillator | 96.46 | 77.16 |
Price Performance
Historical ComparisonAbout NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.